INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

PINNACLE ASSOCIATES LTD's Holding History (CIK: 0000743127)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 135,344 Value ($000) $17,855 Avg Close — Range —
Q4 2024
Shares 144,664 Value ($000) $12,082 Avg Close — Range —
Q3 2024
Shares 176,124 Value ($000) $12,614 Avg Close — Range —
Q2 2024
Shares 171,069 Value ($000) $11,717 Avg Close — Range —
Q1 2024
Shares 173,892 Value ($000) $12,033 Avg Close — Range —
Q4 2023
Shares 176,124 Value ($000) $12,614 Avg Close — Range —
Q3 2023
Shares 177,218 Value ($000) $9,231 Avg Close — Range —
Q2 2023
Shares 184,921 Value ($000) $11,709 Avg Close — Range —
Q1 2023
Shares 191,903 Value ($000) $10,392 Avg Close — Range —
Q4 2022
Shares 195,057 Value ($000) $10,322 Avg Close — Range —
Q3 2022
Shares 198,442 Value ($000) $9,234 Avg Close — Range —
Q2 2022
Shares 206,025 Value ($000) $11,760 Avg Close — Range —
Q1 2022
Shares 206,534 Value ($000) $12,638 Avg Close — Range —
Q4 2021
Shares 216,521 Value ($000) $11,333 Avg Close — Range —
Q3 2021
Shares 217,888 Value ($000) $8,123 Avg Close — Range —
Q2 2021
Shares 225,498 Value ($000) $9,205 Avg Close — Range —
Q1 2021
Shares 222,669 Value ($000) $7,555 Avg Close — Range —
Q4 2020
Shares 247,194 Value ($000) $7,861 Avg Close — Range —
Q3 2020
Shares 264,180 Value ($000) $6,779 Avg Close — Range —
Q2 2020
Shares 275,775 Value ($000) $7,079 Avg Close — Range —